Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Akt
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • DNA Alkylator/Crosslinker
    (1)
  • DNA/RNA Synthesis
    (1)
  • Endogenous Metabolite
    (1)
  • Estrogen/progestogen Receptor
    (1)
  • Glucocorticoid Receptor
    (1)
  • MDM-2/p53
    (1)
  • NO Synthase
    (1)
Filter
Search Result
Results for "

hcc-1937

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
6-Hydroxy-DOPA
6-Hydroxy-DL-DOPA
T2639621373-30-8
6-Hydroxy-DOPA is an allosteric inhibitor of RAD52, it inhibits proliferation of BRCA-deficient cancer cells in vitro and also inhibits APE1.
  • $45
In Stock
Size
QTY
PK11000
T445938275-34-2
PK11000 is a p53 targeting compound, has anti-tumor activities through activation of unstable p53.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
TD52
T355281798328-24-1
TD52 is an orally active inhibitor of cancerous inhibitor of PP2A (CIP2A). TD52 is an Erlotinib derivative and indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter.
  • $88
5 days
Size
QTY
Mifepristone
RU486, RU 38486, C-1073
T110284371-65-3
Mifepristone (C-1073) is a progesterone-receptor (IC50=0.2 nM) and glucocorticoid-receptor antagonist (IC50=2.6 nM). Mifepristone is used to terminate pregnancy, treat uterine fibroids, and treat endometriosis.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
4F-DDC
T209809
4F-DDC is a novel PARP1 inhibitor with an IC50 value of 82 nM, which induces DNA damage and activates the cGAS-STING pathway. Additionally, 4F-DDC inhibits the growth of tumors derived from HCC-1937 xenografts.
  • Inquiry Price
Inquiry
Size
QTY